Reversal of pertussis toxin-induced thermal allodynia by muscarinic cholinergic agonists in mice

Neuropharmacology

Volumn 39, Issue 12, 2000, Pages 2499-2504

  Womer, Daniel E ^a   Shannon, Harlan E ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Allodynia; Central pain; Cholinesterase inhibitors; Mice; Muscarinic receptor agonists; Neuropathic pain; Pertussis toxin

Indexed keywords

2 ETHYL 8 METHYL 2,8 DIAZASPIRO[4.5]DECANE 1,3 DIONE; CHOLINESTERASE INHIBITOR; MU OPIATE RECEPTOR AGONIST; OXOTREMORINE; PERTUSSIS TOXIN; PILOCARPINE; TACRINE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; MALE; MOUSE; NEURALGIA; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

ANIMALS; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEAT; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MUSCARINIC AGONISTS; OXOTREMORINE; PAIN; PAIN MEASUREMENT; PERTUSSIS TOXIN; PILOCARPINE; SUCCINIMIDES; VIRULENCE FACTORS, BORDETELLA;

EID: 0033891884     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00068-X     Document Type: Article

References (32)

1. Adams J.U., Paronis C.A., Holtzman S.G. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo using β-funaltrexamine. Journal of Pharmacology and Experimental Therapeutics. 255:1990;1027-1032.
2. Aley K.O., Levine J.D. Role of protein kinase A in the maintenance of inflammatory pain. Journal of Neuroscience. 19:1999;2181-2186.
3. Arner S., Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 33:1988;11-23.
4. Barber R.P., Phelps P.E., Houser C.R., Crawford G.D., Salvaterra P.M., Vaughn J.E. The morphology and distribution of neurons containing choline acetyltransferase in the adult rat spinal cord: an immunocytochemical study. Journal of Comparative Neurology. 229:1984;329-346.
5. Bennett G.J., Xie Y.-K. A peripheral mononeuropathy in rat that produces disorders of pain sensations like those seen in man. Pain. 33:1988;87-107.
6. Galer B.S. Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology. 45:1995;S17-S25.
7. Gillberg P.G., Ashmark H. Changes in cholinergic and opioid receptors in the rat spinal cord, dorsal root and sciatic nerve after ventral and dorsal root lesion. Journal of Neural Transmission. 85:1991;31-39.
8. Gilman A.G. G-proteins: transducers of receptor-generated signals. Annual Review of Biochemistry. 56:1987;615-649.
9. Gomeza J., Shannon H.E., Kostenis E., Felder C., Zhang L., Brodkin J.et al. Pronounced pharmacologic deficits in m2 muscarinic acetylcholine receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America. 96:1999;1692-1697.
10. Gomeza J., Zhang L., Kostenis E., Felder C., Bymaster F., Brodkin J.et al. Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M4 muscarinic acetylcholine receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America. 96:1999;10483-10488.
11. Hayashi Y., Rabin B.C., Guo T.Z., Maze M. Role of pertussis toxin-sensitive G-proteins in the analgesic and anesthetic actions of a2-adrenergic agonists in the rat. Anesthesiology. 83:1995;816-822.
12. Höglund A.U., Baghdoyan H.A. M2, M3, and M4, but not M1, muscarinic receptor subtypes are present in rat spinal cord. Journal of Pharmacology and Experimental Therapeutics. 281:1997;470-477.
13. Hylden J.L.K., Wilcox G.L. Intrathecal morphine in mice: a new technique. European Journal of Pharmacology. 67:1980;313-316.
14. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
15. Kurose H., Katada T., Amano T., Ui M. Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via alpha-adrenergic, cholinergic, and opiate receptors in neuroblastoma×glioma hybrid cells. Journal of Biological Chemistry. 256:1983;4870-4875.
16. Lee S.H., Kayser V., Desmeules J., Guilbaud G. Differential action of morphine and various opioid agonists on thermal allodynia and hyperalgesia in mononeuropathic rats. Pain. 57:1994;233-240.
17. Mendell L.M. Physiological properties of unmyelinated fiber projection to the spinal cord. Experimental Neurology. 16:1966;316-332.
18. Olesen P.H., Sauerberg P., Treppendahl S., Larsson O., Sheardown M.J., Suzdak P.et al. 3-(3-Alkylthio-1,2,5-thiadiazolyl-4-yl)-1-azabicycles. Structure-activity relationships for antinociception mediated by central muscarinic receptors. European Journal of Medical Chemistry. 31:1996;221-230.
19. Ossipov M.H., Lopez Y., Nicols M.L., Bian D., Porreca F. Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury. Neuroscience Letters. 199:1995;83-86.
20. Richards M.H. Pharmacology and second messenger interactions of cloned muscarinic receptors. Biochemical Pharmacology. 42:1991;1645-1653.
21. Sauerberg P., Olesen P.H., Nielsen S., Treppendahl S., Sheardown M.J., Honore T.et al. Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadizolyl)-1,2,5,6-tetrahydro-1-methylpyridines. Journal of Medical Chemistry. 35:1992;2274-2283.
22. Shannon H.E., Sheardown M.J., Bymaster F.P., Calligaro D.O., DeLapp N.W., Gidda J.et al. Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): a novel analgesic with mixed muscarinic receptor agonist and antagonist activity. Journal of Pharmacology and Experimental Therapeutics. 281:1997;884-894.
23. Shannon H.E., Womer D.E., Bymaster F.P., Calligaro D.O., DeLapp N.C., Mitch C.et al. In vivo pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053), an orally acting antinociceptive muscarinic agonist. Life Sciences. 60:1997;969-976.
24. Sheardown M.J., Shannon H.E., Swedberg M.D.B., Suzdak P.D., Bymaster F.P., Olesen P.H.et al. M1 receptor agonist activity is not a requirement for muscarinic antinociception. Journal of Pharmacology and Experimental Therapeutics. 281:1997;868-875.
25. Swedberg M.D.B., Sheardown M.J., Sauerberg P., Olesen P.H., Suzdak P.D., Hansen K.T.et al. Butylthio[2.2.2] ((+)-3(R)-[4-(butylthio)-1,2,5-thiadiazol-3-yl]-1-azabicyclo[2.2.2]octane): an antinociceptive orally active muscarinic agonist in mouse and rat. Journal of Pharmacology and Experimental Therapeutics. 281:1997;876-883.
26. Taiwo Y.O., Levine J.D. Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience. 44:1991;131-135.
27. Taiwo Y.O., Bjerknes L.K., Goetzl E.J., Levine J.D. Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience. 32:1989;577-580.
28. Wess J. Molecular basis of muscarinic acetylcholine receptor function. Trends in Pharmacological Science. 14:1993;308-313.
29. Womer, D.E., Shannon, H.E. Pharmacologic reversal of pertussis toxin-induced thermal allodynia in mice. Neuropharmacology (in press).
30. Womer D.E., DeLapp N.W., Shannon H.E. Intrathecal pertussis toxin produces hyperalgesia and allodynia in mice. Pain. 70:1997;223-228.
31. Wong C.S., Su Y.F., Chang K.J., Watkins W.D. Intrathecal pertussis toxin treatment attenuates opioid antinociception and reduces high affinity state of opioid receptors. Anesthesiology. 77:1992;691-699.
32. 3H]pirenzepine. European Journal of Pharmacology. 91:1983;147-149.